Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» relapsed or refractory follicular lymphoma
relapsed or refractory follicular lymphoma
Armed with Phase III win, Incyte eyes label expansion for Monjuvi
Clinical Trials Arena
Fri, 08/16/24 - 11:19 am
Incyte
clinical trials
Monjuvi
relapsed or refractory follicular lymphoma
AbbVie, Genmab Secure FDA Label Expansion for Epkinly in Follicular Lymphoma
BioSpace
Thu, 06/27/24 - 11:25 am
FDA
AbbVie
Genmab
Epkinly
relapsed or refractory follicular lymphoma
AbbVie and Genmab report data from follicular lymphoma antibody trial
Clinical Trials Arena
Mon, 12/11/23 - 09:59 am
AbbVie
Genman
clinical trials
epcoritamab
bispecific antibodies
relapsed or refractory follicular lymphoma
Genmab and AbbVie plan next steps for Epkinly in follicular lymphoma
Clinical Trials Arena
Wed, 06/28/23 - 10:27 am
AbbVie
Genmab
Epkinly
clinical trials
relapsed or refractory follicular lymphoma
Novartis (NVS) Wins FDA Nod for Label Expansion of Kymriah
Yahoo/Zacks.com
Tue, 05/31/22 - 10:41 am
Novartis
FDA
Kymriah
CAR-T
relapsed or refractory follicular lymphoma
